Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing SAN FRANCISCO, Dec. 27, 2025…
Partner Reed Kathrein Investigating Alleged Fraudulent Enrollment Metrics and the Direct Causation Linking Operational Failure to Massive Investor Losses SAN FRANCISCO,…